ICG 136
Alternative Names: 123b-33bcCAR; CD123-CD33cCAR T-cells; ICG-136Latest Information Update: 28 Mar 2022
At a glance
- Originator iCell Gene Therapeutics
- Class CAR-T cell therapies; Gene therapies; Immunotherapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute myeloid leukaemia; Haematological malignancies
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for preclinical development in Acute-myeloid-leukaemia in China (Parenteral)
- 28 Mar 2022 No recent reports of development identified for preclinical development in Acute-myeloid-leukaemia in USA (Parenteral)
- 28 Apr 2021 No recent reports of development identified for phase-I development in Haematological-malignancies(Recurrent, Second-line therapy or greater) in China (Parenteral)